A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...

The landscape of rare diseases is constantly changing as new ailments and conditions are identified and reported regularly.

Researchers from the University of Sheffield and Barts Cancer Institute at Queen Mary, University of London have found that ...

Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...

According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...

A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...

Invest in Arcus Biosciences for a strong buying opportunity with promising data, robust pipeline, and significant market ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.